These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 13506329)

  • 1. Evaluation of the antitoxic power of anti-perfringens B, C & D type serums. II. Results of comparative titrations with various homologus perfringens toxins.
    GUILLAUMIE M; KREGUER A; GEOFFROY M; VENTRE F
    Rev Immunol Ther Antimicrob; 1957; 21(4):310-26. PubMed ID: 13506329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the antitoxic power of anti-perfringens B, C & D type serums. I. Properties of toxins used to titrate these immune sera].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; VENTRE F
    Rev Immunol Ther Antimicrob; 1957; 21(4):293-309. PubMed ID: 13506328
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the antitoxic power of anti-perfringens A serums; history].
    GUILLAUMIE M; KREGUER A; GEOFFROY M
    Ann Inst Pasteur (Paris); 1956 Mar; 90(3):265-75. PubMed ID: 13327474
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antitoxic power of types B and C antiperfringens serums].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; VENTRE F
    C R Hebd Seances Acad Sci; 1957 Jul; 245(2):245-8. PubMed ID: 13461392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenicity of various toxinogenic types of Clostridium perfringens administered by mouth to axenic and holoxenic mice].
    Hudault S; Bridonneau C; Raibaud P
    Ann Microbiol (Paris); 1983; 134B(2):277-83. PubMed ID: 6316828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium perfringens and its toxins in minced meat from Kars, Turkey.
    Kamber U; Gokce HI; Elmali M
    Food Addit Contam; 2007 Jul; 24(7):673-8. PubMed ID: 17613051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of A/B toxin and isolation of Clostridium difficile and Clostridium perfringens from foals.
    Silva RO; Ribeiro MG; Palhares MS; Borges AS; Maranhão RP; Silva MX; Lucas TM; Olivo G; Lobato FC
    Equine Vet J; 2013 Nov; 45(6):671-5. PubMed ID: 23452044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of proteinase (minor toxin lambda) in Clostridium perfringens strains from sheep and goats in Iran.
    Ghazi F; Younan M; Ardehalli M; Müller W
    Dtsch Tierarztl Wochenschr; 1997 Oct; 104(10):443-5. PubMed ID: 9394541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
    Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
    Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins.
    Pituch H; Obuch-Woszczatyński P; Wultańska D; van Belkum A; Meisel-Mikołajczyk F; Łuczak M
    Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular typing of Clostridium perfringens toxins recovered from Central Saudi Arabia.
    Moussa IM; Hessan AM
    Saudi Med J; 2011 Jul; 32(7):669-74. PubMed ID: 21748201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.
    Asha NJ; Tompkins D; Wilcox MH
    J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of necrotizing enteritis of suckling piglets (Clostridium perfringens type C enterotoxemia) in industrialized sow breeding units. 4. Epizootiology].
    Köhler B; Zabke J; Sondermann R; Pulst H; Rummler HJ
    Arch Exp Veterinarmed; 1979; 33(4):595-619. PubMed ID: 232840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enteric toxins of Clostridium perfringens.
    Smedley JG; Fisher DJ; Sayeed S; Chakrabarti G; McClane BA
    Rev Physiol Biochem Pharmacol; 2004; 152():183-204. PubMed ID: 15517462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Standardization of the control technics of Clostridium perfringens vaccine. Use of a reference vaccine].
    Bousicaux A
    Dev Biol Stand; 1976; 32():45-61. PubMed ID: 187511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of the anti-alpha titer of anti-perfringens A serums].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; DESBRESLES A
    Ann Inst Pasteur (Paris); 1956 May; 90(5):594-618. PubMed ID: 13327516
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence and prevalence of Clostridium perfringens in polar bears from Svalbard, Norway.
    Jores J; Derocher AE; Staubach C; Aschfalk A
    J Wildl Dis; 2008 Jan; 44(1):155-8. PubMed ID: 18263831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the process of activation and potentiation in mixtures of sterile and o-sterile toxins, type A, of Cl. perfringens and Cl. oedematiens].
    Zhak SP
    Mikrobiol Zh; 1968; 30(4):321-5. PubMed ID: 4308320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.